APA (7th ed.) Citation

Aiko, N., Shimokawa, T., Miyazaki, K., Misumi, Y., Agemi, Y., Ishii, M., . . . Okamoto, H. (2018). Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell lung cancer harboring EGFR mutations. BMC Cancer, 18(1), 1. https://doi.org/10.1186/s12885-018-4911-7

Chicago Style (17th ed.) Citation

Aiko, Naoto, Tsuneo Shimokawa, Kazuhito Miyazaki, Yuki Misumi, Yoko Agemi, Mari Ishii, Yukiko Nakamura, Takeharu Yamanaka, and Hiroaki Okamoto. "Comparison of the Efficacies of First-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Brain Metastasis in Patients with Advanced Non-small-cell Lung Cancer Harboring EGFR Mutations." BMC Cancer 18, no. 1 (2018): 1. https://doi.org/10.1186/s12885-018-4911-7.

MLA (9th ed.) Citation

Aiko, Naoto, et al. "Comparison of the Efficacies of First-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Brain Metastasis in Patients with Advanced Non-small-cell Lung Cancer Harboring EGFR Mutations." BMC Cancer, vol. 18, no. 1, 2018, p. 1, https://doi.org/10.1186/s12885-018-4911-7.